4//SEC Filing
Kutok Jeffery 4
Accession 0000899243-18-022697
CIK 0001113148other
Filed
Aug 16, 8:00 PM ET
Accepted
Aug 17, 4:05 PM ET
Size
7.7 KB
Accession
0000899243-18-022697
Insider Transaction Report
Form 4
Kutok Jeffery
Chief Scientific Officer
Transactions
- Sale
Common Stock
2018-08-15$2.01/sh−8,180$16,421→ 6,133 total - Sale
Common Stock
2018-08-16$2.00/sh−6,133$12,266→ 0 total
Holdings
- 9,542.322(indirect: By 401(k))
Common Stock
Footnotes (2)
- [F1]The dispositions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 29, 2018.
- [F2]The price reported in this line of Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $2.00 to $2.0200, inclusive. The reporting person undertakes to provide to Infinity Pharmaceuticals, Inc., any security holder of Infinity Pharmaceuticals, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote 2.
Documents
Issuer
INFINITY PHARMACEUTICALS, INC.
CIK 0001113148
Entity typeother
Related Parties
1- filerCIK 0001697644
Filing Metadata
- Form type
- 4
- Filed
- Aug 16, 8:00 PM ET
- Accepted
- Aug 17, 4:05 PM ET
- Size
- 7.7 KB